Anoxia is the complete absence of oxygen supply to a tissue or organ. It is distinguished from hypoxia, which describes a partial reduction in oxygen supply rather than total deprivation. In clinical practice, however, the terms are sometimes used interchangeably, and the boundary between severe hypoxia and true anoxia is often blurred in the context of conditions such as cardiac arrest.
The brain is particularly vulnerable to anoxia. Cerebral oxygen stores are exhausted within seconds of oxygen supply stopping, and irreversible neuronal death begins within 4 to 6 minutes without intervention. During cardiac arrest, the cessation of blood flow to the brain creates a state of cerebral anoxia. The extent of subsequent brain injury depends on the duration of anoxia, the core body temperature, and the speed of resumption of perfusion following successful resuscitation.
Anoxic brain injury (also termed hypoxic-ischaemic brain injury, HIBI) is the principal driver of morbidity and mortality in survivors of cardiac arrest. The injury is not fixed at the moment the heart stops; secondary neuronal death continues to occur over hours and days following the arrest, driven by inflammatory cascades, excitotoxicity, and reperfusion injury. Targeted temperature management (TTM) is a neuroprotective strategy that slows the rate of secondary neuronal death by reducing the brain’s metabolic demands in the aftermath of anoxia.
For families and survivors, understanding the distinction between primary anoxic injury (occurring during the arrest itself) and secondary injury (evolving over the following 24 to 72 hours or more) helps explain why the clinical team waits before making neurological predictions. The brain has some capacity for recovery over weeks to months, and early assessments in the intensive care unit can both underestimate and overestimate the degree of lasting injury.
« Back to Glossary Index